P. Rouger

2.4k total citations · 1 hit paper
99 papers, 1.3k citations indexed

About

P. Rouger is a scholar working on Hematology, Physiology and Genetics. According to data from OpenAlex, P. Rouger has authored 99 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Hematology, 29 papers in Physiology and 21 papers in Genetics. Recurrent topics in P. Rouger's work include Blood groups and transfusion (53 papers), Erythrocyte Function and Pathophysiology (27 papers) and Monoclonal and Polyclonal Antibodies Research (17 papers). P. Rouger is often cited by papers focused on Blood groups and transfusion (53 papers), Erythrocyte Function and Pathophysiology (27 papers) and Monoclonal and Polyclonal Antibodies Research (17 papers). P. Rouger collaborates with scholars based in France, Morocco and United States. P. Rouger's co-authors include C Salmon, P.Y. Le Pennec, Ch. Salmon, C Doînel, D. Goossens, Jean‐Pierre Cartron, Dominique Blanchard, Pierre Gane, P. Lambin and Charles T. Salmon and has published in prestigious journals such as Blood, The Journal of Immunology and Biochemical Journal.

In The Last Decade

P. Rouger

93 papers receiving 1.2k citations

Hit Papers

The MAVEN Solar Wind Electron Analyzer 2016 2026 2019 2022 2016 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The MAVEN Solar Wind Electron Analyzer
    2016 250 citations P. Rouger et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Rouger France 19 562 400 303 247 177 99 1.3k
Vagn Andersen Denmark 19 175 0.3× 265 0.7× 335 1.1× 73 0.3× 683 3.9× 59 1.8k
Akira Shimada Japan 29 890 1.6× 133 0.3× 1.1k 3.6× 100 0.4× 282 1.6× 190 2.8k
Yves Rees United Kingdom 16 53 0.1× 97 0.2× 174 0.6× 220 0.9× 170 1.0× 46 1.2k
Mingzhe Han China 20 481 0.9× 73 0.2× 734 2.4× 41 0.2× 391 2.2× 110 1.7k
C. C. Lushbaugh United States 17 64 0.1× 148 0.4× 214 0.7× 31 0.1× 82 0.5× 62 1.1k
Lawrence S. Lamb United States 27 486 0.9× 61 0.2× 369 1.2× 21 0.1× 1.4k 7.8× 79 2.2k
Yukihiro Tomita Japan 19 263 0.5× 17 0.0× 143 0.5× 66 0.3× 434 2.5× 108 1.4k
Jonathan Miller United States 21 557 1.0× 37 0.1× 238 0.8× 5 0.0× 121 0.7× 59 1.4k
Margaret Morris United States 14 65 0.1× 93 0.2× 329 1.1× 31 0.1× 967 5.5× 22 1.5k
M. Furlan Switzerland 21 1.4k 2.5× 114 0.3× 184 0.6× 4 0.0× 1.2k 6.6× 85 2.3k

Countries citing papers authored by P. Rouger

Since Specialization
Citations

This map shows the geographic impact of P. Rouger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Rouger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Rouger more than expected).

Fields of papers citing papers by P. Rouger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Rouger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Rouger. The network helps show where P. Rouger may publish in the future.

Co-authorship network of co-authors of P. Rouger

This figure shows the co-authorship network connecting the top 25 collaborators of P. Rouger. A scholar is included among the top collaborators of P. Rouger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Rouger. P. Rouger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pham, Bach‐Nga, P.Y. Le Pennec, & P. Rouger. (2012). Allo-immunisation anti-érythrocytaire. Transfusion Clinique et Biologique. 19(6). 321–332. 11 indexed citations
2.
Folléa, Gilles, et al.. (2011). European Blood Alliance (EBA) et EuroNet TMS : quels enjeux pour la transfusion de demain ?. Transfusion Clinique et Biologique. 18(2). 106–114. 1 indexed citations
3.
Peyrard, Thierry, Bach‐Nga Pham, P.Y. Le Pennec, & P. Rouger. (2008). Les phénotypes érythrocytaires rares : un enjeu de santé publique. Transfusion Clinique et Biologique. 15(3). 109–119. 19 indexed citations
4.
Rouger, P.. (2007). Blood components: Current challenges. Transfusion Clinique et Biologique. 14(6). 496–498. 1 indexed citations
5.
Lerut, Evelyne, Boudewijn Van Damme, F. Noizat‐Pirenne, et al.. (2005). Do kidd and duffy blood group antigens play a role as minor histocompatibility antigens in renal allograft rejection. American Journal of Transplantation. 5. 253. 4 indexed citations
6.
Moutel, Grégoire, et al.. (2004). L’obligation d’informer le patient sur le risque potentiel de transmission de la MCJ par voie sanguine. Transfusion Clinique et Biologique. 11(2). 101–105. 3 indexed citations
7.
Goossens, D., Xavier Dervillez, Brigitte Réveil, et al.. (2000). A Soluble Recombinant Multimeric Anti-Rh(D) Single-Chain Fv/CR1 Molecule Restores the Immune Complex Binding Ability of CR1-Deficient Erythrocytes. The Journal of Immunology. 164(3). 1505–1513. 35 indexed citations
8.
Rouger, P.. (1999). [From malaria to post-transfusional malaria].. PubMed. 6(1). 72–4. 3 indexed citations
9.
10.
Pennec, P.Y. Le, et al.. (1996). Les accidents immuno-hémolytiques transfusionnels IV. Analyse, risques et prévention. Transfusion Clinique et Biologique. 3(3). 167–180. 13 indexed citations
11.
Pennec, P.Y. Le, Pierre Gane, F. Noizat‐Pirenne, et al.. (1996). Flow cytometric evaluation of non anti-RH1(D) monoclonal Rh antibodies. Transfusion Clinique et Biologique. 3(6). 433–435. 1 indexed citations
12.
Pennec, P.Y. Le & P. Rouger. (1995). Anémies hémolytiques immunologiques De l'auto-immunité à l'immunisation anti-médicaments. Transfusion Clinique et Biologique. 2(2). 123–133. 2 indexed citations
13.
Kaplan, C., Jean‐Yves Muller, C Doînel, et al.. (1990). HLA-Associated Susceptibility to Acquired Immune Deficiency Syndrome in HIV-1-Seropositive Subjects. Human Heredity. 40(5). 290–298. 33 indexed citations
14.
Salmon, D., P. Lambin, A.M. Couroucé, et al.. (1990). Essai de prédiction de l'évolution vers le SIDA d'une cohorte de 77 séropositifs : intérêt de l'antigénémie p24 et du taux des IgA sériques. 33(1). 21–29.
15.
Rouger, P., et al.. (1990). Les interleukines : médiateurs non spécifiques de la réaction immunitaire. PubMed. 33(1). 49–69.
16.
Chouchane, Lotfi, et al.. (1989). Amino acid sequence of the variable domains of a human anti-Rh(c) antibody: Presence of an unusually long CDR3 in the λ chain. Molecular Immunology. 26(12). 1179–1186. 1 indexed citations
17.
Pennec, P.Y. Le, P. Rouger, Michelle Klein, et al.. (1989). A serologic study of red cells and sera from 18 Rh:32,‐46 (RN/RN) persons. Transfusion. 29(9). 798–802. 17 indexed citations
18.
Rouger, P. & L. Edelman. (1988). Murine monoclonal antibodies associated with Rh17, Rh29, and Rh46 antigens. Transfusion. 28(1). 52–55. 6 indexed citations
19.
Rouger, P. & D. Goossens. (1988). Challenge of Human Monoclonal Antibodies. Scandinavian Journal of Immunology. 28(3). 383–386. 1 indexed citations
20.
Rouger, P., Pierre Gane, & C Salmon. (1980). Haemagglutination kinetics using a continuous-flow system.. Journal of Clinical Pathology. 33(9). 885–887. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vagn Andersen Breakdown of academic impact, for papers by Akira Shimada Breakdown of academic impact, for papers by Yves Rees Breakdown of academic impact, for papers by Mingzhe Han Breakdown of academic impact, for papers by C. C. Lushbaugh Breakdown of academic impact, for papers by Lawrence S. Lamb Breakdown of academic impact, for papers by Yukihiro Tomita Breakdown of academic impact, for papers by Jonathan Miller Breakdown of academic impact, for papers by Margaret Morris Breakdown of academic impact, for papers by M. Furlan
Rankless by CCL
2026